• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

26/05/2025 16:03

Indo US Bio-Tech Q4 net profit zooms 607.69% at Rs 3.68 cr

The company reported standalone net profit of Rs 3.68 crore for the quarter ended March 31, 2025 as compared to Rs 0.52 crore in the same period last year, registering a year-on-year growth of 607.69 per cent.

Net revenue of the company rose triple digit by 111.67 per cent at Rs 33.38 crore in January-March quarter of this fiscal as against Rs 15.77 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 94.59 per cent to Rs 28.80 crore from Rs 14.80 crore in year ago period.

Other Income dipped by 42.86 per cent at Rs 0.12 crore versus (Mar'24 Rs 0.21 crore).

Operating Profit surged by 372.16 per cent to Rs 4.58 crore as against Rs 0.97 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 122.89 per cent in March quarter.

Interest declined by 27.78 per cent y-o-y to Rs 0.26 crore, while Taxation increased by 72.73 per cent at Rs 0.19 crore (Mar'24 Rs 0.11 crore).